Actively Recruiting

Phase Not Applicable
Age: 40Years - 60Years
All Genders
NCT07079553

Combined Effects of Transcutaneous Electrical Diaphragmatic Stimulation With ACBT'S in Copd

Led by Riphah International University · Updated on 2025-07-23

50

Participants Needed

1

Research Sites

23 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The combined effects of transcutaneous electrical diaphragmatic stimulation (TEDS) and active cycle of breathing techniques (ACBTs) in patients with chronic obstructive pulmonary disease (COPD) conducted as a randomized controlled trial at Gulab Devi Hospital, the study involved 50 participants aged 40 to 60 with mild to moderate COPD. Participants were divided into two groups, one receiving both TEDS and ACBT, and the other receiving only ACBT. Over 12 weeks, improvements in lung function, oxygen saturation, exercise capacity, and quality of life were measured using spirometry, pulse oximetry, the 6-minute walk test, and the St. George's Respiratory Questionnaire. Both groups showed significant improvement, but the group receiving ACBT alone showed a slightly higher mean rank in some outcomes. The study concludes that while both interventions are beneficial, ACBT alone may offer more consistent improvements. It recommends including respiratory muscle assessments and combining interventions with education and exercise in future research.

CONDITIONS

Official Title

Combined Effects of Transcutaneous Electrical Diaphragmatic Stimulation With ACBT'S in Copd

Who Can Participate

Age: 40Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with mild to moderate COPD
  • Aged between 40 and 60 years
  • Both male and female participants
  • Productive cough lasting more than 2 months
  • Oxygen saturation above 88% without oxygen supply
Not Eligible

You will not qualify if you...

  • Having uncontrolled hypertension
  • Presence of cardiac diseases
  • Active smokers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Arjumand

Lahore, Punjab Province, Pakistan, 40100

Actively Recruiting

Loading map...

Research Team

I

imran amjad, phd

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here